Search Result

Results for "

PI(4

" in MedChemExpress (MCE) Product Catalog:

By Targets:	PI4K (49) Akt (1) Apoptosis (3) ATM/ATR (1) Autophagy (2) Biochemical Assay Reagents (9) Drug Isomer (1) Endogenous Metabolite (1) Enterovirus (2) Fluorescent Dye (2) HCV (5) Hedgehog (1) MAP4K (1) Molecular Glues (1) Parasite (12) PI3K (12) PI4P5K (1) PKG (2) Potassium Channel (1) Reference Standards (4) Reverse Transcriptase (1) Small Interfering RNA (siRNA) (13) Virus Protease (1)
By Research Areas:	Cancer (14) Infection (30) Inflammation/Immunology (1) Metabolic Disease (3) Neurological Disease (2)
Oligonucleotides:	Rat Pre-designed siRNA Sets (4) Phospholipids (7) Mouse Pre-designed siRNA Sets (4) Human Pre-designed siRNA Sets (5) siRNAs (13)

Inhibitors & Agonists

Screening Libraries

Fluorescent Dyes

Biochemical Assay Reagents

Natural
Products

Recombinant Proteins

Antibodies

Oligonucleotides

Targets Recommended: PI4K

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-12016

KU-55933 Maximum Cited Publications 62 Publications Verification	ATM/ATR Autophagy	Cancer
KU-55933 is a potent ATM inhibitor with an IC₅₀ and K_i of 12.9 and 2.2 nM, respectively, and is highly selective for ATM as compared to DNA-PK, PI3K/PI4K, ATR and mTOR.

HY-103489

PI-273 5+ Cited Publications	PI4K Apoptosis	Cancer
PI-273 is a first reversibly and specific *phosphatidylinositol 4-kinase (PI4KIIα)* inhibitor with an IC₅₀ of 0.47 μM. PI-273 can inhibit breast cancer cell proliferation, block the cell cycle and induce cell apoptosis .

HY-125118

GSK-A1 2 Publications Verification	PI4K HCV	Infection
GSK-A1 is a selective *type III phosphatidylinositol 4-kinase PI4KA (PI4KIIIα)* inhibitor with a pIC₅₀ of 8.5-9.8. GSK-A1 inhibits PtdIns(4,5)P2 resynthesis with an IC₅₀ of about 3 nM. GSK-A1 potently decreases the levels of PtdIns(4)P with a negligible effect on PtdIns(4,5)P2. GSK-A1 has the potential for anti-hepatitis C virus (HCV) research .

HY-12046

PIK-93 5+ Cited Publications	PI4K PI3K Virus Protease	Cancer
PIK-93 is the first potent, synthetic PI4K (PI4KIIIβ) inhibitor with IC₅₀ of 19 nM, and also inhibits PI3Kγ and PI3Kα with IC₅₀ of 16 nM and 39 nM, respectively.

HY-106005

MMV390048 3 Publications Verification	Parasite PI4K	Infection
MMV390048 is a representative of a new chemical class of Plasmodium *PI4K* inhibitor (K_d ^app=0.3 µM). MMV390048 binds to the ATP binding site of Plasmodium PI4K and does not bind to other P. falciparum and human kinases apart from human PIP4K2C, thus alleviating potential kinase-mediated safety concerns. MMV390048 is an antimalarial agent .

HY-100198

PI4KIIIbeta-IN-10 10+ Cited Publications	PI4K PI3K	Infection
PI4KIIIbeta-IN-10 is a potent PI4KIIIβ inhibitor with an IC₅₀ of 3.6 nM.

HY-115675

NC03	PI4K	Others
NC03 is a *PI4K2A* inhibitor and reducing agent. NC03 inhibits the activity of *PI4K2A, thereby reducing the production of PI4P* in the cellular compartments where *PI4K2A* functions. NC03 rapidly induces a decrease in *PI4P* pools in the Golgi and endosomal compartments. NC03 reduces *PI4P* production in Rab7-positive late endosomes .

HY-U00426

BF738735 5 Publications Verification	PI4K Reverse Transcriptase	Infection
BF738735 is a phosphatidylinositol 4-kinase III beta (PI4KIIIβ) inhibitor with an IC₅₀ of 5.7 nM.

HY-108313

T-00127_HEV1 4 Publications Verification	PI4K	Infection
T-00127_HEV1 is a phosphatidylinositol 4-kinase III beta (PI4KB) inhibitor with an IC₅₀ of 60 nM.

HY-12912

KDU691	PI4K Parasite	Infection
KDU691, an imidazopyrazine with potent anti-parasitic activity against blood stage schizonts, gametocytes and liver stages, is a **Plasmodium PI4K** inhibitor. KDU691 selectively inhibits dihydroartemisinin-pretreated Plasmodium falciparum ring-stage parasites .

HY-112613

UCB9608 1 Publications Verification	PI4K	Inflammation/Immunology
UCB9608 is a potent, selective and orally active PI4KIIIβ inhibitor, with an IC₅₀ of 11 nM, selective over PI3KC2 α, β, and γ lipid kinases. UCB9608 improves metabolic stability and exhibits excellent pharmacokinetic profile, acts as a potent immunosuppressive agent .

HY-19798

PI4KIIIbeta-IN-9 5 Publications Verification	PI4K PI3K	Cancer
PI4KIIIbeta-IN-9 is a potent PI4KIIIβ inhibitor with an IC₅₀ of 7 nM. PI4KIIIbeta-IN-9 also inhibits PI3Kδ and PI3Kγ with IC₅₀s of 152 nM and 1046 nM, respectively.

HY-15679

PI4KIII beta inhibitor 3 3 Publications Verification	PI4K	Cancer
PI4KIII beta inhibitor 3 is a novel and high effective PI4KIIIβ inhibitor with IC₅₀ of 5.7 nM.

HY-100603

GSK-F1	PI4K PI3K	Infection
GSK-F1 (Compound F1) is an orally active *PI4KA* inhibitor with pIC₅₀ values of 8.0, 5.9, 5.8, 5.9, 5.9 and 6.4 against PI4KA, PI4KB, PI3KA, PI3KB, PI3KG and PI3KD, respectively. GSK-F1 can be used for HCV infection research .

HY-175067

PtdIns-(4,5)-P2 (1,2-dihexanoyl) sodium salt DHPI-4,5-P2 sodium salt; PI(4,5)P2 (6:0/6:0) sodium salt; PIP2[4',5'](6:0/6:0) sodium salt	Biochemical Assay Reagents	Others
PtdIns-(4,5)-P2 (1,2-dihexanoyl) (sodium salt) is a synthetic analog of natural Ptdlns with C₆:0 fatty acids at the sn-1 and sn-2 positions.

HY-106012

PI4K-IN-1	PI4K PI3K	Cancer
PI4K-IN-1 (compound 44) is a potent *PI4KIII* inhibitor, with pIC₅₀ values of 9.0 and 6.6 for PI4KIIIα and PI4KIIIβ, respectively. PI4K-IN-1 also inhibits PI3Kα/β/γ/δ, with pIC₅₀ values of 4.0/<3.7/5.0/<4.1, respectively .

HY-110248

MI 14	PI4K HCV	Infection
MI 14 is a selective PI4KIIIβ inhibitor with IC₅₀s of 54 nM, >100 μM, >100 μM for PI4KIIIβ, PI4KIIIα, PI4KIIα, respectively. MI 14 has antiviral activity against HCV 1b, CVB3, HRVM, HVC 2a .

HY-148075

PI4KIIIbeta-IN-11	PI4K	Infection
PI4KIIIbeta-IN-11 is an inhibitor of PI4KIIIβ, with a mean pIC₅₀ value of at least 9.1. PI4KIIIβ plays a key role in diseases research of RNA viruses and Plasmodium falciparum .

HY-18748

BQR-695 1 Publications Verification NVP-BQR695	PI4K Parasite	Infection
BQR-695 is a PI4KIIIβ inhibitor with IC₅₀s of 80 and 3.5 nM for human PI4KIIIβ and Plasmodium variant of PI4KIIIβ, respectively.

HY-112435

UCT943	PI4K Parasite	Infection
UCT943 is a next-generation Plasmodium falciparum *PI4K* inhibitor. UCT943 inhibits the P. vivax PI4K (PvPI4K) enzyme with an IC₅₀ of 23 nM .

HY-100603A

(S)-GSK-F1	PI3K PI4K	Infection
(S)-GSK-F1 (Compound 28) is an inhibitor for type III phosphatidylinositol 4-kinase α (PI4KIIIα). (S)-GSK-F1 inhibits PI4Kα, PI4Kβ, PI4Kγ, PI3Kα, PI3Kβ and PI3Kδ with pIC₅₀ of 8.3, 6.0, 5.6, 5.6, 5.1 and 5.6, respectively. (S)-GSK-F1 exhibits anti-hepatitis C virus (HCV) activity through inhibition of HCV replication. (S)-GSK-F1 exhibits moderate pharmacokinetic characters in rat model .

HY-103583

KDU731	PI4K Parasite	Infection
KDU731, an orally active C. parvum *PI4K* inhibitor with an IC₅₀ value of 25 nM, blocks Cryptosporidium infection in vitro and in vivo . KDU731 is a promising agent candidate for the treatment of diarrhea caused by Cryptosporidium and meets a broad range of safety .

HY-174134

PI4Kβ/PKG-IN-2	PI4K PKG Parasite	Infection
PI4Kβ/PKG-IN-2 (Compound 20) is an orally active dual inhibitor of Plasmodium phosphatidylinositol 4-kinase beta (PI4Kβ) and cGMP-dependent protein kinase (PKG). PI4Kβ/PKG-IN-2 has potent inhibitory effects on Plasmodium. PI4Kβ/PKG-IN-2 is promising for research of malaria .

HY-157712

*08:0 PI(4,5)P2 ammonium*	Biochemical Assay Reagents	Others
08:0 PI(4,5)P2 ammonium is suitable for identifying its binding site at the transient receptor potential vanilloid 4 (TRPV 4 N) terminus .

HY-177725

MG degrader 2	Molecular Glues PI4K	Cancer
MG degrader 2 (Compound CM-2) is a CRBN-dependent molecular glue degrader. MG degrader 2 induces ZFP91, FIZ1 and *PI4KB* degradation. MG degrader 2 has anti-proliferative activity against MM.1S cells (IC₅₀ = 162 nM). MG degrader 2 can be used for the research of cancer, such as multiple myeloma .

HY-112608

CHMFL-PI3KD-317	PI3K	Cancer
CHMFL-PI3KD-317 is a highly potent, selective and orally active PI3Kδ inhibitor, with an IC₅₀ of 6 nM, and exhibits over 10-1500 fold selectivity over other class I, II and III PIKK family isoforms, such as PI3Kα (IC₅₀, 62.6 nM), PI3Kβ (IC₅₀, 284 nM), PI3Kγ (IC₅₀, 202.7 nM), PIK3C2A (IC₅₀, >10000 nM), PIK3C2B (IC₅₀, 882.3 nM), VPS34 (IC₅₀, 1801.7 nM), PI4KIIIA (IC₅₀, 574.1 nM) and PI4KIIIB (IC₅₀, 300.2 nM). CHMFL-PI3KD-317 inhibits PI3Kδ-mediated Akt T308 phosphorylation in Raji cells, with an EC₅₀ of 4.3 nM. CHMFL-PI3KD-317 has antiproliferative effects on cancer cells .

HY-178775

PI4K-IN-3	PI4K Parasite MAP4K PI3K	Infection
PI4K-IN-3 (Compound 27) is an orally active *PI4K* inhibitor with an IC₅₀ of 1.9  nM for Plasmodium vivax PI4K. PI4K-IN-3 has no hERG channel inhibition and mammalian cytotoxicity. PI4K-IN-3 has significant selectivity against the human MINK1 and *MAP4K4* kinases but with low selectivity against human PI3Kα and PI4Kβ. PI4K-IN-3 has potent antimalarial activity and significantly reduces parasitaemia in NSG mice mouse models of Plasmodium falciparum malaria .

HY-175557

PI4K-IN-2	PI4K Enterovirus	Infection
PI4K-IN-2 (Compound 30) is a highly selective type III phosphatidylinositol 4-kinase β (PI4KB) inhibitor (IC₅₀=0.015 μM). PI4K-IN-2 is promising for research of human rhinovirus (HRV) .

HY-175732

PI4Kβ-IN-1	PI4K Parasite	Infection
PI4Kβ-IN-1 is an orally active and selective PI4Kβ inhibitor, with an IC₅₀ of 0.9 nM. PI4Kβ-IN-1 exhibits inhibitory activity against all stages of the P. falciparum life cycle, including blood, liver, and transmission stages. PI4Kβ-IN-1 demonstrates potent antimalarial efficacy in the mouse model infected with Plasmodium falciparum. PI4Kβ-IN-1 can be used for the study of malaria caused by Plasmodium falciparum .

HY-118525

AL-9	HCV PI4K	Infection
AL-9 is a inhibitor of PI4KIIIα, with the IC₅₀ of 0.57 μM, that can inhibit HCV replication .

HY-150598

*CHMFL-PI4K-127*	PI4K PI3K	Infection
CHMFL-PI4K-127 (compound 15g) is an orally active, potent and high selective *PfPI4K* (Plasmodium falciparum PI4K kinase) inhibitor, with an IC₅₀ of 0.9 nM. CHMFL-PI4K-127 exhibits potent activity against 3D7 Plasmodium falciparum, with an EC₅₀ of 25.1 nM. CHMFL-PI4K-127 shows antimalaria efficacy .

HY-174130

PI4Kβ/PKG-IN-1	Parasite PI4K PKG	Infection
PI4Kβ/PKG-IN-1 (Compound 19) is an orally active dual inhibitor targeting Plasmodium phosphatidylinositol 4-kinase beta (PI4Kβ) and cGMP-dependent protein kinase (PKG). PI4Kβ/PKG-IN-1 exhibits potent antiplasmodial activity. PI4Kβ/PKG-IN-1 is promising for research of malaria .

HY-157645

*18:0-20:4 PI(4)P ammonium*	Biochemical Assay Reagents	Others
18:0-20:4 PI(4)P ammonium is a fatty acid.

HY-172255

PI4KIII beta inhibitor 4	PI4K Apoptosis Autophagy PI3K Akt	Cancer
PI4KIII beta inhibitor 4 (Compound 16) is a selective PI4KIIIβ inhibitor with an IC₅₀ of 0.005 μM. PI4KIIIβ inhibitor 4 induces tumor cell apoptosis, cell cycle arrest, and autophagy by inhibiting the PI3K/AKT pathway. PI4KIIIβ inhibitor 4 can be used in the study of cancer .

HY-172256

PI4KIII beta inhibitor 5	PI4K	Cancer
PI4KIII beta inhibitor 5 is a PI4KIIIβ inhibitor with an IC₅₀ of 19 nM. PI4KIII beta inhibitor 5 can induce cancer cell apoptosis (Apoptosis), cell cycle arrest at the G2/M phase, and autophagy (Autophagy) by inhibiting the PI3K/AKT pathway. PI4KIII beta inhibitor 5 has also demonstrated significant antitumor activity in the H446 xenograft model of small cell lung cancer. PI4KIII beta inhibitor 5 can be used for research in the field of cancer therapy .

HY-RS10468

Pi4ka Rat Pre-designed siRNA Set A	Small Interfering RNA (siRNA) PI4K	Others
Pi4ka Rat Pre-designed siRNA Set A contains three designed siRNAs for Pi4ka gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

Pi4ka Rat Pre-designed siRNA Set A Pi4ka Rat Pre-designed siRNA Set A

HY-RS10469

PI4KB Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA) PI4K	Others
PI4KB Human Pre-designed siRNA Set A contains three designed siRNAs for PI4KB gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PI4KB Human Pre-designed siRNA Set A PI4KB Human Pre-designed siRNA Set A

HY-RS10470

Pi4kb Mouse Pre-designed siRNA Set A	Small Interfering RNA (siRNA) PI4K	Others
Pi4kb Mouse Pre-designed siRNA Set A contains three designed siRNAs for Pi4kb gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Pi4kb Mouse Pre-designed siRNA Set A Pi4kb Mouse Pre-designed siRNA Set A

HY-RS10467

Pi4ka Mouse Pre-designed siRNA Set A	Small Interfering RNA (siRNA) PI4K	Others
Pi4ka Mouse Pre-designed siRNA Set A contains three designed siRNAs for Pi4ka gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Pi4ka Mouse Pre-designed siRNA Set A Pi4ka Mouse Pre-designed siRNA Set A

HY-RS10471

Pi4kb Rat Pre-designed siRNA Set A	Small Interfering RNA (siRNA) PI4K	Others
Pi4kb Rat Pre-designed siRNA Set A contains three designed siRNAs for Pi4kb gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

Pi4kb Rat Pre-designed siRNA Set A Pi4kb Rat Pre-designed siRNA Set A

HY-RS10466

PI4KA Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA) PI4K	Others
PI4KA Human Pre-designed siRNA Set A contains three designed siRNAs for PI4KA gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PI4KA Human Pre-designed siRNA Set A PI4KA Human Pre-designed siRNA Set A

HY-RS10464

PI4K2A Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
PI4K2A Human Pre-designed siRNA Set A contains three designed siRNAs for PI4K2A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PI4K2A Human Pre-designed siRNA Set A PI4K2A Human Pre-designed siRNA Set A

HY-RS20578

Pi4k2a Mouse Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
Pi4k2a Mouse Pre-designed siRNA Set A contains three designed siRNAs for Pi4k2a gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Pi4k2a Mouse Pre-designed siRNA Set A Pi4k2a Mouse Pre-designed siRNA Set A

HY-RS10465

PI4K2B Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
PI4K2B Human Pre-designed siRNA Set A contains three designed siRNAs for PI4K2B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PI4K2B Human Pre-designed siRNA Set A PI4K2B Human Pre-designed siRNA Set A

HY-RS12700

SERPINA4 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
SERPINA4 Human Pre-designed siRNA Set A contains three designed siRNAs for SERPINA4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SERPINA4 Human Pre-designed siRNA Set A SERPINA4 Human Pre-designed siRNA Set A

HY-157703

*18:1 PI(4,5)P2* 1,2-Dioleoyl-sn-glycero-3-phospho-1′-myo-inositol-4′,5′-bisphosphate ammonium	Biochemical Assay Reagents
18:1 PI(4,5)P2 (1,2-Dioleoyl-sn-glycero-3-phospho-(1′-myo-inositol-4′,5′-bisphosphate) (ammonium)) is a kind of biochemical reagent.

HY-161357

KR-27370	PI4K	Infection
KR-27370 (compound 7f) is an antiviral agent and selective PI4KIIIβ/PI4KIIIα inhibitor (IC₅₀: 3.1 nM/15.8 nM), against hRV, Ke Saatchivirus and other enteroviruses have inhibitory activity .

HY-E70631

PIP5K1A Recombinant Human Active Lipid Kinase	PI3K	Cancer
PIP5K1A phosphorylates PI4P to synthesize the important signalling phospholipid PI(4,5)P2. This phospholipid also serves as the substrate for PI3K for conversion into PI(3,4,5)P3 to stimulate cell growth and survival. PIP5K1A has been directly implicated in breast cancer and prostate cancer. PIP5K1A Recombinant Human Active Lipid Kinase is a recombinant PIP5K1A protein that can be used to study PIP5K1A-related functions .

HY-139406

1,2-Dioctanoyl-sn-glycero-3-phospho-1'-myo-inositol-4'-phosphate ammonium PtdIns-(4)-P1 (1,2-dioctanoyl) ammonium; 08:0 PI(4)P ammonium	Biochemical Assay Reagents	Neurological Disease
1,2-Dioctanoyl-sn-glycero-3-phospho-(1'-myo-inositol-4'-phosphate) (PtdIns-(4)-P1 (1,2-dioctanoyl)) ammonium is a synthetic phosphatidylinositol. 1,2-Dioctanoyl-sn-glycero-3-phospho-(1'-myo-inositol-4'-phosphate) ammonium can be used for the research of signal transduction research .

HY-163765

Antimalarial agent 41	PI4K Potassium Channel	Infection
Antimalarial agent 41 (Compound 17) exhibits antimalarial activity, which inhibits Plasmodium falciparum with an IC₅₀ of 40 nM (NF54 strain) and 76 nM (K1 strain). Antimalarial agent 41 is an inhibitor for P. falciparum phosphatidylinositol-4-kinase β (Pf PI4K) and hERG channel, with an IC₅₀ of 53 nM and 3 μM. Antimalarial agent 41 exhibits cytotoxicity to CHO cells with an IC₅₀ of 34 μM. Antimalarial agent 41 ameliorates the malaria infection and exhibits good pharmacokinetic characters in mouse models .

Cat. No.	Product Name

HY-L009

Kinase Inhibitor Library

3,849 compounds

Kinase is an enzyme that adds phosphate groups to other molecules. This process is known as phosphorylation. Protein phosphorylation is a key aspect in the regulation of a large number of cellular processes including cellular division, metabolism, signal transduction, and so on. There are over 500 kinases encoded by the human genome and it has been estimated that kinases regulate approximately 50% of cellular functions. Kinases are a large group of drug targets in drug discovery. Kinase inhibitors are an important class of drugs that block certain enzymes involved in diseases such as cancer and inflammatory disorders.

Kinase inhibitor library designed by MCE contains 3,849 kinase inhibitors and regulators mainly targeting protein kinases (VEGFR, EGFR, BTK, CDK, Akt, etc.), lipid kinases (PI3K, PI4K, SK, etc.) and carbohydrate kinases (Hexokinase), and is a useful tool for kinase drug discovery and related research.

HY-L009M

Kinase Inhibitor Library Mini

270 compounds

Kinases is a class of enzymes that adds chemicals called phosphates to other molecules, such as sugars or proteins. Protein phosphorylation serves as a critical regulatory mechanism for numerous cellular processes including cell division, metabolism, and signal transduction, with approximately 50% of cellular functions in humans being regulated by kinase activity. In drug discovery, kinases represent a major category of therapeutic targets, and kinase inhibitors constitute an important class of pharmaceuticals that block the activity of specific disease-associated enzymes, particularly in cancer and inflammatory disorders. Small molecule kinase inhibitors represent one of the fastest-growing drug categories, having received U.S. Food and Drug Administration (FDA) approval for both oncological and non-oncological indications. As of September 2023, over 70 FDA-approved small molecule kinase inhibitors are commercially available.

The MCE Kinase Inhibitor Library Mini contains 270 kinase inhibitors primarily targeting protein kinases (VEGFR, EGFR, BTK, CDK, Akt, etc.), lipid kinases (PI3K, PI4K, SK, etc.), and carbohydrate kinases. This collection includes 1-3 highly specific representative compounds per target, optimized for screening of kinase-related drug targets in pharmaceutical research.

Cat. No.	Product Name	Type

HY-157712

*08:0 PI(4,5)P2 ammonium*	Biochemical Assay Reagents
08:0 PI(4,5)P2 ammonium is suitable for identifying its binding site at the transient receptor potential vanilloid 4 (TRPV 4 N) terminus .

HY-157703

*18:1 PI(4,5)P2* 1,2-Dioleoyl-sn-glycero-3-phospho-1′-myo-inositol-4′,5′-bisphosphate ammonium	Biochemical Assay Reagents
18:1 PI(4,5)P2 (1,2-Dioleoyl-sn-glycero-3-phospho-(1′-myo-inositol-4′,5′-bisphosphate) (ammonium)) is a kind of biochemical reagent.

HY-139406

1,2-Dioctanoyl-sn-glycero-3-phospho-1'-myo-inositol-4'-phosphate ammonium PtdIns-(4)-P1 (1,2-dioctanoyl) ammonium; 08:0 PI(4)P ammonium	Biochemical Assay Reagents
1,2-Dioctanoyl-sn-glycero-3-phospho-(1'-myo-inositol-4'-phosphate) (PtdIns-(4)-P1 (1,2-dioctanoyl)) ammonium is a synthetic phosphatidylinositol. 1,2-Dioctanoyl-sn-glycero-3-phospho-(1'-myo-inositol-4'-phosphate) ammonium can be used for the research of signal transduction research .

Species:	Human (4)
Tag:	His (4) GST (3)
Source:	HEK293 (1) Sf9 insect cells (2) E. coli (1)

Cat. No.	Compare	Product Name	Species	Source	Image

HY-P71143

	Serpin A4 Protein, Human (HEK293, His) 1 Publications Verification Kallistatin; Kallikrein Inhibitor; Peptidase Inhibitor 4; PI-4; Serpin A4; SERPINA4; KST; PI4	Human	HEK293
	Serpin A4 Protein inhibits tissue kallikrein's amidolytic and kininogenase activities by forming a heat- and SDS-stable equimolar complex with the enzyme. Tissue kallikrein concurrently cleaves the reactive site of Serpin A4, producing a small C-terminal fragment. The protein, existing as a monomer and occasionally forming homodimers, demonstrates its regulatory role in modulating tissue kallikrein-mediated enzymatic activities. Serpin A4 Protein, Human (HEK293, His) is the recombinant human-derived Serpin A4 protein, expressed by HEK293 , with C-6*His labeled tag.

HY-P701742

	PI4KB Protein, Human (Active, sf9, His, GST) PI4KB; Phosphatidylinositol 4-kinase beta; PI4K-beta; PI4Kbeta; PtdIns 4-kinase beta; NPIK; PI4K92; PI4KIII	Human	Sf9 insect cells
	The PI4KB protein is a key enzyme that initiates the production of 1,4,5-trisphosphate inositol (PIP) by phosphorylating phosphatidylinositol (PI). In addition to myo-inositol signaling, it is involved in mitotic Golgi disassembly and Golgi-to-plasma membrane trafficking, which is critical for cell membrane dynamics. PI4KB Protein, Human (sf9, His, GST) is the recombinant human-derived PI4KB protein, expressed by sf9 insect cells , with N-8*His, N-GST labeled tag.

HY-P703333

	PI4K2B Protein, Human (sf9, His, GST) Phosphatidylinositol 4-kinase type 2-beta; Phosphatidylinositol 4-kinase type II-beta; PI4KII-BETA; PI4K2B; Homo sapiens; Human; PI4KII-BETA; Kinase; Transferase; 2.7.1.67	Human	Sf9 insect cells
	PI4K2B Protein, Human (sf9, His, GST) is the recombinant human-derived PI4K2B, expressed by sf9 insect cells , with His, GST labeled tag. ,

HY-P703335

	PI4K2A Protein, Human (His, GST) Phosphatidylinositol 4-kinase type 2-alpha; Phosphatidylinositol 4-kinase type II-alpha; PI4K2A; Homo sapiens; Human; Kinase; Transferase; 2.7.1.67	Human	E. coli
	PI4K2A Protein, Human (His, GST) is the recombinant human-derived PI4K2A, expressed by E. coli , with His, GST labeled tag. ,

Compare Products


Products	In-stock - + Add to Cart
Cat. No.
Species
Source
Tag
Accession
Gene ID
Molecular Weight
Purity
Endotoxin Level
Biological Activity
Appearance
Formulation
Storage & Stability
Shipping
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote

Host:	Mouse (2)
Reactivity:	Human (1) mouse (1) rat (1) human (1)
Application:	ICC/IF (1) IF-Tissue (1) IP (1) WB (2) ELISA (2)
Isotype:	IgG1 (1)
Conjugation:	Non-conjugated (2)
Clonality:	Monoclonal (1)
Modification:	Unmodified (2)

Cat. No.	Compare	Product Name	Application	Reactivity	Image

HY-P810069

	PI 4-kinase II α Antibody (YA9413)	WB, ICC/IF, IF-Tissue, IP, ELISA	human, mouse, rat
	PI 4-kinase II α Antibody (YA9413) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to PI 4-kinase II α.

HY-P85302

	NPT1 Antibody (YA4994) SLC17A1; NPT1; Sodium-dependent phosphate transport protein 1; Na; +; /PI cotransporter 1; Na/Pi-4; Renal Na; +; -dependent phosphate cotransporter 1; Renal sodium-dependent phosphate transport protein 1; Renal sodium-phosphate transport protei	WB, ELISA	Human
	NPT1 Antibody (YA4994) is a Mouse-derived and non-conjugated monoclonal antibody, targeting to NPT1.